These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29369166)

  • 61. Accuracy of Pooled-Cohort Equation and SCORE cardiovascular risk calculators to identify individuals with high coronary atherosclerotic burden - implications for statin treatment.
    Tralhão A; Ferreira AM; Gonçalves Pde A; Rodrigues R; Costa C; Guerreiro S; Cardim N; Marques H
    Coron Artery Dis; 2016 Nov; 27(7):573-9. PubMed ID: 27285280
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography.
    Callister TQ; Raggi P; Cooil B; Lippolis NJ; Russo DJ
    N Engl J Med; 1998 Dec; 339(27):1972-8. PubMed ID: 9869668
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial.
    Dirajlal-Fargo S; Kinley B; Jiang Y; Longenecker CT; Hileman CO; Debanne S; McComsey GA
    AIDS; 2015 Jan; 29(3):313-21. PubMed ID: 25686680
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Three-dimensional morphological response of lipid-rich coronary plaques to statin therapy: a serial optical coherence tomography study.
    Wang Z; Cho YS; Soeda T; Minami Y; Xing L; Jia H; Aguirre A; Vergallo R; Lee H; Fujimoto JG; Yu B; Jang IK
    Coron Artery Dis; 2016 Aug; 27(5):350-6. PubMed ID: 27105047
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of combination therapy of ezetimibe and rosuvastatin on regression of coronary atherosclerosis in patients with coronary artery disease.
    Masuda J; Tanigawa T; Yamada T; Nishimura Y; Sasou T; Nakata T; Sawai T; Fujimoto N; Dohi K; Miyahara M; Nishikawa M; Nakamura M; Ito M
    Int Heart J; 2015 May; 56(3):278-85. PubMed ID: 25902885
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential Plasma Protein Regulation and Statin Effects in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients Utilizing a Proteomics Approach.
    deFilippi C; Toribio M; Wong LP; Sadreyev R; Grundberg I; Fitch KV; Zanni MV; Lo J; Sponseller CA; Sprecher E; Rashidi N; Thompson MA; Cagliero D; Aberg JA; Braun LR; Stanley TL; Lee H; Grinspoon SK
    J Infect Dis; 2020 Aug; 222(6):929-939. PubMed ID: 32310273
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of Targeting Inflammation With Salsalate: The TINSAL-CVD Randomized Clinical Trial on Progression of Coronary Plaque in Overweight and Obese Patients Using Statins.
    Hauser TH; Salastekar N; Schaefer EJ; Desai T; Goldfine HL; Fowler KM; Weber GM; Welty F; Clouse M; Shoelson SE; Goldfine AB;
    JAMA Cardiol; 2016 Jul; 1(4):413-23. PubMed ID: 27438317
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Atheroma progression in hyporesponders to statin therapy.
    Kataoka Y; St John J; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):990-5. PubMed ID: 25722430
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study.
    Ostad MA; Eggeling S; Tschentscher P; Schwedhelm E; Böger R; Wenzel P; Meinertz T; Munzel T; Warnholtz A
    Atherosclerosis; 2009 Jul; 205(1):227-32. PubMed ID: 19150064
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Patient-specific prediction of coronary plaque growth from CTA angiography: a multiscale model for plaque formation and progression.
    Parodi O; Exarchos TP; Marraccini P; Vozzi F; Milosevic Z; Nikolic D; Sakellarios A; Siogkas PK; Fotiadis DI; Filipovic N
    IEEE Trans Inf Technol Biomed; 2012 Sep; 16(5):952-65. PubMed ID: 22665513
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.
    Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
    Eur Heart J; 2013 Nov; 34(41):3182-90. PubMed ID: 23886915
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of statin therapy on coronary plaque burden and composition assessed by coronary computed tomographic angiography: a systematic review and meta-analysis.
    Andelius L; Mortensen MB; Nørgaard BL; Abdulla J
    Eur Heart J Cardiovasc Imaging; 2018 Aug; 19(8):850-858. PubMed ID: 29617981
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy.
    Puri R; Nissen SE; Shao M; Uno K; Kataoka Y; Kapadia SR; Tuzcu EM; Nicholls SJ
    Am J Cardiol; 2014 Nov; 114(10):1465-72. PubMed ID: 25282317
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Does spotty calcification attenuate the response of nonculprit plaque to statin therapy?: A serial optical coherence tomography study.
    Afolabi A; Mustafina I; Zhao L; Li L; Sun R; Hu S; Zhang S; Jia H; Guilio G; Yu B
    Catheter Cardiovasc Interv; 2018 Feb; 91(S1):582-590. PubMed ID: 29359491
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of statin therapy on plaque regression following acute coronary syndrome: a meta-analysis of prospective trials.
    Tang X; Yang Y; Luo S; Zhao Y; Lu C; Luo Y; Zhang F; Xiao H
    Coron Artery Dis; 2016 Dec; 27(8):636-649. PubMed ID: 27388482
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of ezetimibe/atorvastatin combination on oxidized low density lipoprotein cholesterol in patients with coronary artery disease or coronary artery disease equivalent.
    Azar RR; Badaoui G; Sarkis A; Azar M; Aydanian H; Harb S; Achkouty G; Kassab R
    Am J Cardiol; 2010 Jul; 106(2):193-7. PubMed ID: 20599002
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).
    Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ
    Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Accuracy of statin assignment using the 2013 AHA/ACC Cholesterol Guideline versus the 2001 NCEP ATP III guideline: correlation with atherosclerotic plaque imaging.
    Johnson KM; Dowe DA
    J Am Coll Cardiol; 2014 Sep; 64(9):910-9. PubMed ID: 25169177
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial.
    Toribio M; Fitch KV; Stone L; Zanni MV; Lo J; de Filippi C; Sponseller CA; Lee H; Grundberg I; Thompson MA; Aberg JA; Grinspoon SK
    EBioMedicine; 2018 Sep; 35():58-66. PubMed ID: 30174281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.